Curr Opin Nephrol Hypertens

• 

  Publication Venue For

  • Redlining has led to increasing rates of nephrolithiasis in minoritized populations: a hypothesis..  32:103-109. 2023
  • Actions of immune cells in the hypertensive kidney..  29:515-522. 2020
  • Therapeutic options for chronic kidney disease-associated pulmonary hypertension..  29:497-507. 2020
  • The varying roles of macrophages in kidney injury and repair..  29:286-292. 2020
  • Renin-angiotensin system inhibition in advanced chronic kidney disease: how low can the kidney function go?.  28:171-177. 2019
  • Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response..  27:314-322. 2018
  • Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease..  27:258-267. 2018
  • Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug..  27:102-112. 2018
  • Renal effects of cytokines in hypertension..  27:70-76. 2018
  • Digital pathology in nephrology clinical trials, research, and pathology practice..  26:450-459. 2017
  • Something old, something new, something borrowed, something black..  26:241-242. 2017
  • Angiotensin converting enzyme 2 and the kidney..  25:59-66. 2016
  • Bones and stones, edition 2015..  24:301-302. 2015
  • Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease..  24:260-267. 2015
  • Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease..  23:411-419. 2014
  • The pursuit of truth and beauty..  23:329-330. 2014
  • Disparities in the burden, outcomes, and care of chronic kidney disease..  23:298-305. 2014
  • New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management..  22:656-662. 2013
  • Transplanting the highly sensitized patient: trials and tribulations..  22:681-688. 2013
  • Innovations in bones and stones..  22:369-370. 2013
  • Mineral metabolism: confusion to clarity..  21:353-354. 2012
  • The kidney and hypertension: novel insights from transgenic models..  21:171-178. 2012
  • The beehive and the merry-go-round in mineral metabolism..  20:329-330. 2011
  • New insights into angiotensin receptor actions: from blood pressure to aging..  20:84-88. 2011
  • Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease..  19:335-342. 2010
  • Fibroblast growth factor 23 and the future of phosphorus management..  18:463-468. 2009